GlassScriptPhysician profile
Nora P Vasquez
NPI 1447296645
$1,199.73
in general payments reported to CMS, 2019-2025
15 companies · $417 in 2025
The $417 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $212 · 2022: $54.11 · 2023: $124 · 2024: $99.73 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $257.48 | 2019-2025 | Evenity, Prolia, Prolia |
| Novo Nordisk INC | $234.51 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $169.28 | 2019-2025 | Mounjaro, Zepbound |
| Cochlear Americas | $159.81 | 2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Gilead Sciences, INC. | $123.74 | 2023 | Descovy |
| Pfizer INC. | $45.46 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $39.92 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $33.22 | 2024 | Fasenra |
| Glaxosmithkline, LLC. | $29.32 | 2025 | Bexsero, Shingrix, Arexvy |
| Hologic Sales and Service, LLC | $22.46 | 2024 | Aptima, Thinprep 2000 Processor |
| Metuchen Pharmaceuticals | $20.91 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.56 | 2020 | |
| Currax Pharmaceuticals LLC | $15.40 | 2025 | Contrave |
| Exact Sciences Corporation | $14.47 | 2025 | The Cologuard Plus Collection Kit |
| Optinose US, INC. | $14.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nora Vasquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.